Assessment of potential predictive factors of dupilumab response in patients with moderate‐to‐severe atopic dermatitis
Gemma Melé‐Ninot,
Laia Curto‐Barredo,
Montserrat Bonfill‐Ortí
et al.
Abstract:BackgroundDupilumab has shown to be an effective and safe treatment for patients with moderate‐to‐severe atopic dermatitis (AD).ObjectiveTo evaluate the predictive factors of response (PRF) in patients with moderate‐to‐severe AD treated with dupilumab.MethodsObservational, retrospective and multicentre study conducted on adult patients diagnosed with moderate‐to‐severe AD treated with dupilumab, with a post‐treatment follow‐up of at least 16 weeks. The primary endpoints were EASI‐75 and the IGA scale at week 5… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.